webinar register page

COVID-19 Pediatric Vaccine Guidance
As an important step in the prevention of COVID-19, Pfizer-BioNTech has submitted an application for authorization of their COVID-19 vaccine for use in children ages 5 to 11 years. On October 29, FDA's advisory committee endorsed the vaccine, however further action is still needed from the FDA and CDC before emergency use authorization is granted and recommendations for pediatric use are approved.

Join NACCHO on November 9 to receive updated information regarding approval, guidelines, and recommendations for pediatric COVID-19 vaccine. A CDC representative will join the discussion to present on the high-level outcomes of the FDA and CDC’s advisory committee meetings as well as an overview of the pediatric vaccine operational planning guide. Additionally, representatives from Pfizer will join to provide information on product packaging, shipping and storage, preparation, administration, adverse event reporting, and resources specific to the pediatric vaccine

Note: this webinar will NOT be recorded but resources will be available shortly after.

Nov 9, 2021 03:00 PM in Eastern Time (US and Canada)

Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: Preparedness.